» Articles » PMID: 33584977

Perspectives of Pluripotent Stem Cells in Livestock

Overview
Date 2021 Feb 15
PMID 33584977
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The recent progress in derivation of pluripotent stem cells (PSCs) from farm animals opens new approaches not only for reproduction, genetic engineering, treatment and conservation of these species, but also for screening novel drugs for their efficacy and toxicity, and modelling of human diseases. Initial attempts to derive PSCs from the inner cell mass of blastocyst stages in farm animals were largely unsuccessful as either the cells survived for only a few passages, or lost their cellular potency; indicating that the protocols which allowed the derivation of murine or human embryonic stem (ES) cells were not sufficient to support the maintenance of ES cells from farm animals. This scenario changed by the innovation of induced pluripotency and by the development of the 3 inhibitor culture conditions to support naïve pluripotency in ES cells from livestock species. However, the long-term culture of livestock PSCs while maintaining the full pluripotency is still challenging, and requires further refinements. Here, we review the current achievements in the derivation of PSCs from farm animals, and discuss the potential application areas.

Citing Articles

Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.

Cotta G, Teixeira Dos Santos R, Costa G, Lacerda S Int J Mol Sci. 2024; 25(20).

PMID: 39456792 PMC: 11507014. DOI: 10.3390/ijms252011009.


Mechanisms of Embryonic Stem Cell Pluripotency Maintenance and Their Application in Livestock and Poultry Breeding.

Wang Z, Gong W, Yao Z, Jin K, Niu Y, Li B Animals (Basel). 2024; 14(12).

PMID: 38929361 PMC: 11201147. DOI: 10.3390/ani14121742.


Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.

Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M Mol Cancer. 2023; 22(1):189.

PMID: 38017433 PMC: 10683363. DOI: 10.1186/s12943-023-01873-0.


How genome editing changed the world of large animal research.

Fischer K, Schnieke A Front Genome Ed. 2023; 5:1272687.

PMID: 37886655 PMC: 10598601. DOI: 10.3389/fgeed.2023.1272687.


Perspectives in Genome-Editing Techniques for Livestock.

Popova J, Bets V, Kozhevnikova E Animals (Basel). 2023; 13(16).

PMID: 37627370 PMC: 10452040. DOI: 10.3390/ani13162580.


References
1.
Tu Z, Yang W, Yan S, Guo X, Li X . CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases. Mol Neurodegener. 2015; 10:35. PMC: 4524001. DOI: 10.1186/s13024-015-0031-x. View

2.
Kaufman M, Robertson E, Handyside A, Evans M . Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol. 1983; 73:249-61. View

3.
Muzaffar M, Selokar N, Singh K, Zandi M, Singh M, Shah R . Equivalency of buffalo (Bubalus bubalis) embryonic stem cells derived from fertilized, parthenogenetic, and hand-made cloned embryos. Cell Reprogram. 2012; 14(3):267-79. PMC: 3369701. DOI: 10.1089/cell.2011.0090. View

4.
Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

5.
Cong X, Zhang S, Ellis M, Luo J . Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells. Stem Cells Dev. 2019; 28(19):1288-1298. DOI: 10.1089/scd.2019.0136. View